The financial media has invested plenty of ink and bandwidth to explore the trend of weaker-than-usual dividends this... Read More...
Pandemic or not, American consumers are both willing and able to spend... Read More...
Charles River Laboratories ($234; CRL) may not be a household name, but it flows... Read More...